HEADER IMMUNE SYSTEM 04-APR-20 6YJP TITLE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN GLYCOSYLATED NKP30 AND ITS TITLE 2 DEGLYCOSYLATED TUMOUR LIGAND B7-H6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3 LIGAND 1; COMPND 3 CHAIN: C, D, E; COMPND 4 SYNONYM: B7 HOMOLOG 6,B7-H6; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; COMPND 9 CHAIN: A, B; COMPND 10 SYNONYM: ACTIVATING NATURAL KILLER RECEPTOR P30,NATURAL KILLER CELL COMPND 11 P30-RELATED PROTEIN,NKP30; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NCR3LG1, B7H6; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293S GNTI(-); SOURCE 10 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-3022; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PTW5SEC; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 GENE: NCR3, 1C7, LY117; SOURCE 18 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 19 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM_CELL_LINE: HEK293S GNTI(-); SOURCE 22 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-3022; SOURCE 23 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 24 EXPRESSION_SYSTEM_PLASMID: PTW5SEC KEYWDS NK CELL RECEPTOR, RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR T.SKALOVA,J.DOHNALEK,O.SKOREPA,B.KALOUSKOVA,S.PAZICKY,J.BLAHA,O.VANEK REVDAT 4 24-JAN-24 6YJP 1 REMARK REVDAT 3 30-SEP-20 6YJP 1 JRNL REVDAT 2 05-AUG-20 6YJP 1 JRNL REVDAT 1 29-JUL-20 6YJP 0 JRNL AUTH O.SKOREPA,S.PAZICKY,B.KALOUSKOVA,J.BLAHA,C.ABREU,T.JECMEN, JRNL AUTH 2 M.ROSULEK,A.FISH,A.SEDIVY,K.HARLOS,J.DOHNALEK,T.SKALOVA, JRNL AUTH 3 O.VANEK JRNL TITL NATURAL KILLER CELL ACTIVATION RECEPTOR NKP30 JRNL TITL 2 OLIGOMERIZATION DEPENDS ON ITS N -GLYCOSYLATION. JRNL REF CANCERS (BASEL) V. 12 2020 JRNL REFN ESSN 2072-6694 JRNL PMID 32708305 JRNL DOI 10.3390/CANCERS12071998 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 (LORESTR PIPELINE)) REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 25738 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.275 REMARK 3 R VALUE (WORKING SET) : 0.272 REMARK 3 FREE R VALUE : 0.322 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1348 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.18 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1671 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.5040 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.5780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6837 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 105.5 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 155.5 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 19.96000 REMARK 3 B22 (A**2) : -5.81000 REMARK 3 B33 (A**2) : -15.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.37000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.536 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.852 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 62.879 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7080 ; 0.005 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9627 ; 1.590 ; 1.652 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 868 ; 6.952 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 359 ;33.713 ;22.423 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1156 ;21.118 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 43 ;19.778 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 935 ; 0.120 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5415 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 4 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 C 23 245 D 23 245 6069 0.170 0.050 REMARK 3 2 C 25 245 E 25 245 5991 0.170 0.050 REMARK 3 3 D 25 245 E 25 245 5904 0.180 0.050 REMARK 3 4 A 18 128 B 18 128 3136 0.160 0.050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.10 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6YJP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-APR-20. REMARK 100 THE DEPOSITION ID IS D_1292107555. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27102 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 48.950 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.97100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MORDA, PHASER REMARK 200 STARTING MODEL: 3PV6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE PH 6.7, 11.7 % REMARK 280 PEG 6000, 10 MG/ML MIXTURE OF BOTH PROTEINS, MICRO-SEEDED WITH REMARK 280 CRUSHED NEEDLE-SHAPED CRYSTALS, VAPOR DIFFUSION, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 83.02200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.23100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 83.02200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 43.23100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -14.68149 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 110.32643 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE C 22 REMARK 465 HIS C 248 REMARK 465 HIS C 249 REMARK 465 HIS C 250 REMARK 465 HIS C 251 REMARK 465 HIS C 252 REMARK 465 HIS C 253 REMARK 465 HIS C 254 REMARK 465 GLY C 255 REMARK 465 ILE D 22 REMARK 465 GLN D 151 REMARK 465 VAL D 152 REMARK 465 GLY D 153 REMARK 465 MET D 154 REMARK 465 LYS D 155 REMARK 465 GLU D 156 REMARK 465 ASN D 157 REMARK 465 GLU D 158 REMARK 465 ASP D 159 REMARK 465 THR D 246 REMARK 465 HIS D 247 REMARK 465 HIS D 248 REMARK 465 HIS D 249 REMARK 465 HIS D 250 REMARK 465 HIS D 251 REMARK 465 HIS D 252 REMARK 465 HIS D 253 REMARK 465 HIS D 254 REMARK 465 GLY D 255 REMARK 465 ILE A 16 REMARK 465 THR A 17 REMARK 465 LYS A 129 REMARK 465 GLU A 130 REMARK 465 GLY A 131 REMARK 465 THR A 132 REMARK 465 HIS A 133 REMARK 465 HIS A 134 REMARK 465 HIS A 135 REMARK 465 HIS A 136 REMARK 465 HIS A 137 REMARK 465 HIS A 138 REMARK 465 HIS A 139 REMARK 465 HIS A 140 REMARK 465 GLY A 141 REMARK 465 ILE B 16 REMARK 465 THR B 17 REMARK 465 LYS B 129 REMARK 465 GLU B 130 REMARK 465 GLY B 131 REMARK 465 THR B 132 REMARK 465 HIS B 133 REMARK 465 HIS B 134 REMARK 465 HIS B 135 REMARK 465 HIS B 136 REMARK 465 HIS B 137 REMARK 465 HIS B 138 REMARK 465 HIS B 139 REMARK 465 HIS B 140 REMARK 465 GLY B 141 REMARK 465 ILE E 22 REMARK 465 THR E 23 REMARK 465 GLY E 24 REMARK 465 LEU E 149 REMARK 465 ASP E 150 REMARK 465 GLN E 151 REMARK 465 VAL E 152 REMARK 465 GLY E 153 REMARK 465 MET E 154 REMARK 465 LYS E 155 REMARK 465 THR E 246 REMARK 465 HIS E 247 REMARK 465 HIS E 248 REMARK 465 HIS E 249 REMARK 465 HIS E 250 REMARK 465 HIS E 251 REMARK 465 HIS E 252 REMARK 465 HIS E 253 REMARK 465 HIS E 254 REMARK 465 GLY E 255 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG C 90 CB - CG - CD ANGL. DEV. = 15.6 DEGREES REMARK 500 ARG A 67 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 LYS E 183 CB - CA - C ANGL. DEV. = 12.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN C 41 1.73 80.35 REMARK 500 CYS C 48 108.27 -165.88 REMARK 500 THR C 71 -69.94 -100.83 REMARK 500 THR C 127 129.93 -37.61 REMARK 500 ASP C 150 63.35 75.52 REMARK 500 VAL C 152 79.35 41.94 REMARK 500 GLU C 156 59.39 -117.04 REMARK 500 ASN C 157 -30.69 -141.32 REMARK 500 ASP C 193 35.93 70.37 REMARK 500 SER C 217 -123.76 47.58 REMARK 500 SER C 218 -117.27 54.56 REMARK 500 GLN C 219 92.81 -65.73 REMARK 500 ASN D 41 2.97 81.01 REMARK 500 CYS D 48 112.30 -164.07 REMARK 500 THR D 71 -73.83 -84.34 REMARK 500 LYS D 74 -61.56 -91.91 REMARK 500 GLU D 75 79.43 68.25 REMARK 500 THR D 127 128.79 -34.94 REMARK 500 SER D 217 173.30 79.57 REMARK 500 LEU D 235 55.72 26.33 REMARK 500 ASP A 58 -58.13 73.93 REMARK 500 VAL A 60 36.12 -97.90 REMARK 500 ALA A 91 55.83 -141.84 REMARK 500 HIS A 101 2.69 -69.59 REMARK 500 SER A 104 175.64 179.74 REMARK 500 LEU A 115 -61.44 -125.22 REMARK 500 ASP B 58 -48.26 72.45 REMARK 500 LEU B 115 -57.52 -125.41 REMARK 500 ASN E 41 -1.60 81.66 REMARK 500 CYS E 48 110.09 -163.87 REMARK 500 PHE E 72 -134.91 -124.80 REMARK 500 LYS E 74 -46.85 -132.56 REMARK 500 PHE E 82 -168.41 -116.60 REMARK 500 ASP E 84 -15.17 92.94 REMARK 500 THR E 127 129.44 -35.91 REMARK 500 PRO E 170 -167.24 -70.97 REMARK 500 GLN E 182 98.17 -48.28 REMARK 500 SER E 217 115.30 -36.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PV6 RELATED DB: PDB REMARK 900 3PV6 CONTAINS COMPLEX OF THE SAME MOLECULES BUT PRODUCED IN A REMARK 900 DIFFERENT EXPRESSION SYSTEM DBREF 6YJP C 24 244 UNP Q68D85 NR3L1_HUMAN 24 244 DBREF 6YJP D 24 244 UNP Q68D85 NR3L1_HUMAN 24 244 DBREF 6YJP A 19 130 UNP O14931 NCTR3_HUMAN 19 130 DBREF 6YJP B 19 130 UNP O14931 NCTR3_HUMAN 19 130 DBREF 6YJP E 24 244 UNP Q68D85 NR3L1_HUMAN 24 244 SEQADV 6YJP ILE C 22 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP THR C 23 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP SER C 212 UNP Q68D85 CYS 212 ENGINEERED MUTATION SEQADV 6YJP GLY C 245 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP THR C 246 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS C 247 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS C 248 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS C 249 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS C 250 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS C 251 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS C 252 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS C 253 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS C 254 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP GLY C 255 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP ILE D 22 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP THR D 23 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP SER D 212 UNP Q68D85 CYS 212 ENGINEERED MUTATION SEQADV 6YJP GLY D 245 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP THR D 246 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS D 247 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS D 248 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS D 249 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS D 250 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS D 251 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS D 252 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS D 253 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS D 254 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP GLY D 255 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP ILE A 16 UNP O14931 EXPRESSION TAG SEQADV 6YJP THR A 17 UNP O14931 EXPRESSION TAG SEQADV 6YJP GLY A 18 UNP O14931 EXPRESSION TAG SEQADV 6YJP GLY A 131 UNP O14931 EXPRESSION TAG SEQADV 6YJP THR A 132 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS A 133 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS A 134 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS A 135 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS A 136 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS A 137 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS A 138 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS A 139 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS A 140 UNP O14931 EXPRESSION TAG SEQADV 6YJP GLY A 141 UNP O14931 EXPRESSION TAG SEQADV 6YJP ILE B 16 UNP O14931 EXPRESSION TAG SEQADV 6YJP THR B 17 UNP O14931 EXPRESSION TAG SEQADV 6YJP GLY B 18 UNP O14931 EXPRESSION TAG SEQADV 6YJP GLY B 131 UNP O14931 EXPRESSION TAG SEQADV 6YJP THR B 132 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS B 133 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS B 134 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS B 135 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS B 136 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS B 137 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS B 138 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS B 139 UNP O14931 EXPRESSION TAG SEQADV 6YJP HIS B 140 UNP O14931 EXPRESSION TAG SEQADV 6YJP GLY B 141 UNP O14931 EXPRESSION TAG SEQADV 6YJP ILE E 22 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP THR E 23 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP SER E 212 UNP Q68D85 CYS 212 ENGINEERED MUTATION SEQADV 6YJP GLY E 245 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP THR E 246 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS E 247 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS E 248 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS E 249 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS E 250 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS E 251 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS E 252 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS E 253 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP HIS E 254 UNP Q68D85 EXPRESSION TAG SEQADV 6YJP GLY E 255 UNP Q68D85 EXPRESSION TAG SEQRES 1 C 234 ILE THR GLY ASP LEU LYS VAL GLU MET MET ALA GLY GLY SEQRES 2 C 234 THR GLN ILE THR PRO LEU ASN ASP ASN VAL THR ILE PHE SEQRES 3 C 234 CYS ASN ILE PHE TYR SER GLN PRO LEU ASN ILE THR SER SEQRES 4 C 234 MET GLY ILE THR TRP PHE TRP LYS SER LEU THR PHE ASP SEQRES 5 C 234 LYS GLU VAL LYS VAL PHE GLU PHE PHE GLY ASP HIS GLN SEQRES 6 C 234 GLU ALA PHE ARG PRO GLY ALA ILE VAL SER PRO TRP ARG SEQRES 7 C 234 LEU LYS SER GLY ASP ALA SER LEU ARG LEU PRO GLY ILE SEQRES 8 C 234 GLN LEU GLU GLU ALA GLY GLU TYR ARG CYS GLU VAL VAL SEQRES 9 C 234 VAL THR PRO LEU LYS ALA GLN GLY THR VAL GLN LEU GLU SEQRES 10 C 234 VAL VAL ALA SER PRO ALA SER ARG LEU LEU LEU ASP GLN SEQRES 11 C 234 VAL GLY MET LYS GLU ASN GLU ASP LYS TYR MET CYS GLU SEQRES 12 C 234 SER SER GLY PHE TYR PRO GLU ALA ILE ASN ILE THR TRP SEQRES 13 C 234 GLU LYS GLN THR GLN LYS PHE PRO HIS PRO ILE GLU ILE SEQRES 14 C 234 SER GLU ASP VAL ILE THR GLY PRO THR ILE LYS ASN MET SEQRES 15 C 234 ASP GLY THR PHE ASN VAL THR SER SER LEU LYS LEU ASN SEQRES 16 C 234 SER SER GLN GLU ASP PRO GLY THR VAL TYR GLN CYS VAL SEQRES 17 C 234 VAL ARG HIS ALA SER LEU HIS THR PRO LEU ARG SER ASN SEQRES 18 C 234 PHE THR GLY THR HIS HIS HIS HIS HIS HIS HIS HIS GLY SEQRES 1 D 234 ILE THR GLY ASP LEU LYS VAL GLU MET MET ALA GLY GLY SEQRES 2 D 234 THR GLN ILE THR PRO LEU ASN ASP ASN VAL THR ILE PHE SEQRES 3 D 234 CYS ASN ILE PHE TYR SER GLN PRO LEU ASN ILE THR SER SEQRES 4 D 234 MET GLY ILE THR TRP PHE TRP LYS SER LEU THR PHE ASP SEQRES 5 D 234 LYS GLU VAL LYS VAL PHE GLU PHE PHE GLY ASP HIS GLN SEQRES 6 D 234 GLU ALA PHE ARG PRO GLY ALA ILE VAL SER PRO TRP ARG SEQRES 7 D 234 LEU LYS SER GLY ASP ALA SER LEU ARG LEU PRO GLY ILE SEQRES 8 D 234 GLN LEU GLU GLU ALA GLY GLU TYR ARG CYS GLU VAL VAL SEQRES 9 D 234 VAL THR PRO LEU LYS ALA GLN GLY THR VAL GLN LEU GLU SEQRES 10 D 234 VAL VAL ALA SER PRO ALA SER ARG LEU LEU LEU ASP GLN SEQRES 11 D 234 VAL GLY MET LYS GLU ASN GLU ASP LYS TYR MET CYS GLU SEQRES 12 D 234 SER SER GLY PHE TYR PRO GLU ALA ILE ASN ILE THR TRP SEQRES 13 D 234 GLU LYS GLN THR GLN LYS PHE PRO HIS PRO ILE GLU ILE SEQRES 14 D 234 SER GLU ASP VAL ILE THR GLY PRO THR ILE LYS ASN MET SEQRES 15 D 234 ASP GLY THR PHE ASN VAL THR SER SER LEU LYS LEU ASN SEQRES 16 D 234 SER SER GLN GLU ASP PRO GLY THR VAL TYR GLN CYS VAL SEQRES 17 D 234 VAL ARG HIS ALA SER LEU HIS THR PRO LEU ARG SER ASN SEQRES 18 D 234 PHE THR GLY THR HIS HIS HIS HIS HIS HIS HIS HIS GLY SEQRES 1 A 126 ILE THR GLY LEU TRP VAL SER GLN PRO PRO GLU ILE ARG SEQRES 2 A 126 THR LEU GLU GLY SER SER ALA PHE LEU PRO CYS SER PHE SEQRES 3 A 126 ASN ALA SER GLN GLY ARG LEU ALA ILE GLY SER VAL THR SEQRES 4 A 126 TRP PHE ARG ASP GLU VAL VAL PRO GLY LYS GLU VAL ARG SEQRES 5 A 126 ASN GLY THR PRO GLU PHE ARG GLY ARG LEU ALA PRO LEU SEQRES 6 A 126 ALA SER SER ARG PHE LEU HIS ASP HIS GLN ALA GLU LEU SEQRES 7 A 126 HIS ILE ARG ASP VAL ARG GLY HIS ASP ALA SER ILE TYR SEQRES 8 A 126 VAL CYS ARG VAL GLU VAL LEU GLY LEU GLY VAL GLY THR SEQRES 9 A 126 GLY ASN GLY THR ARG LEU VAL VAL GLU LYS GLU GLY THR SEQRES 10 A 126 HIS HIS HIS HIS HIS HIS HIS HIS GLY SEQRES 1 B 126 ILE THR GLY LEU TRP VAL SER GLN PRO PRO GLU ILE ARG SEQRES 2 B 126 THR LEU GLU GLY SER SER ALA PHE LEU PRO CYS SER PHE SEQRES 3 B 126 ASN ALA SER GLN GLY ARG LEU ALA ILE GLY SER VAL THR SEQRES 4 B 126 TRP PHE ARG ASP GLU VAL VAL PRO GLY LYS GLU VAL ARG SEQRES 5 B 126 ASN GLY THR PRO GLU PHE ARG GLY ARG LEU ALA PRO LEU SEQRES 6 B 126 ALA SER SER ARG PHE LEU HIS ASP HIS GLN ALA GLU LEU SEQRES 7 B 126 HIS ILE ARG ASP VAL ARG GLY HIS ASP ALA SER ILE TYR SEQRES 8 B 126 VAL CYS ARG VAL GLU VAL LEU GLY LEU GLY VAL GLY THR SEQRES 9 B 126 GLY ASN GLY THR ARG LEU VAL VAL GLU LYS GLU GLY THR SEQRES 10 B 126 HIS HIS HIS HIS HIS HIS HIS HIS GLY SEQRES 1 E 234 ILE THR GLY ASP LEU LYS VAL GLU MET MET ALA GLY GLY SEQRES 2 E 234 THR GLN ILE THR PRO LEU ASN ASP ASN VAL THR ILE PHE SEQRES 3 E 234 CYS ASN ILE PHE TYR SER GLN PRO LEU ASN ILE THR SER SEQRES 4 E 234 MET GLY ILE THR TRP PHE TRP LYS SER LEU THR PHE ASP SEQRES 5 E 234 LYS GLU VAL LYS VAL PHE GLU PHE PHE GLY ASP HIS GLN SEQRES 6 E 234 GLU ALA PHE ARG PRO GLY ALA ILE VAL SER PRO TRP ARG SEQRES 7 E 234 LEU LYS SER GLY ASP ALA SER LEU ARG LEU PRO GLY ILE SEQRES 8 E 234 GLN LEU GLU GLU ALA GLY GLU TYR ARG CYS GLU VAL VAL SEQRES 9 E 234 VAL THR PRO LEU LYS ALA GLN GLY THR VAL GLN LEU GLU SEQRES 10 E 234 VAL VAL ALA SER PRO ALA SER ARG LEU LEU LEU ASP GLN SEQRES 11 E 234 VAL GLY MET LYS GLU ASN GLU ASP LYS TYR MET CYS GLU SEQRES 12 E 234 SER SER GLY PHE TYR PRO GLU ALA ILE ASN ILE THR TRP SEQRES 13 E 234 GLU LYS GLN THR GLN LYS PHE PRO HIS PRO ILE GLU ILE SEQRES 14 E 234 SER GLU ASP VAL ILE THR GLY PRO THR ILE LYS ASN MET SEQRES 15 E 234 ASP GLY THR PHE ASN VAL THR SER SER LEU LYS LEU ASN SEQRES 16 E 234 SER SER GLN GLU ASP PRO GLY THR VAL TYR GLN CYS VAL SEQRES 17 E 234 VAL ARG HIS ALA SER LEU HIS THR PRO LEU ARG SER ASN SEQRES 18 E 234 PHE THR GLY THR HIS HIS HIS HIS HIS HIS HIS HIS GLY HET NAG C 301 14 HET NAG D 301 14 HET NAG A 201 14 HET NAG B 201 14 HET NAG E 301 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 6 NAG 5(C8 H15 N O6) HELIX 1 AA1 ASN C 57 THR C 59 5 3 HELIX 2 AA2 SER C 96 LYS C 101 1 6 HELIX 3 AA3 GLN C 113 GLU C 116 5 4 HELIX 4 AA4 ASN D 57 THR D 59 5 3 HELIX 5 AA5 SER D 96 LYS D 101 1 6 HELIX 6 AA6 GLN D 113 ALA D 117 5 5 HELIX 7 AA7 VAL A 61 GLU A 65 5 5 HELIX 8 AA8 ALA A 81 HIS A 87 1 7 HELIX 9 AA9 VAL B 61 GLU B 65 5 5 HELIX 10 AB1 ALA B 81 HIS B 87 1 7 HELIX 11 AB2 ASN E 57 THR E 59 5 3 HELIX 12 AB3 SER E 96 LYS E 101 1 6 HELIX 13 AB4 GLN E 113 ALA E 117 5 5 SHEET 1 AA1 2 LYS C 27 GLU C 29 0 SHEET 2 AA1 2 ASN C 49 PHE C 51 -1 O PHE C 51 N LYS C 27 SHEET 1 AA2 6 THR C 35 PRO C 39 0 SHEET 2 AA2 6 LEU C 129 VAL C 140 1 O GLN C 136 N GLN C 36 SHEET 3 AA2 6 GLY C 118 VAL C 126 -1 N VAL C 124 O ALA C 131 SHEET 4 AA2 6 MET C 61 SER C 69 -1 N GLY C 62 O VAL C 125 SHEET 5 AA2 6 VAL C 76 PHE C 82 -1 O VAL C 78 N TRP C 65 SHEET 6 AA2 6 HIS C 85 ALA C 88 -1 O HIS C 85 N PHE C 82 SHEET 1 AA3 2 VAL C 44 ILE C 46 0 SHEET 2 AA3 2 LEU C 107 LEU C 109 -1 O LEU C 107 N ILE C 46 SHEET 1 AA4 3 VAL C 194 THR C 196 0 SHEET 2 AA4 3 PHE C 207 LYS C 214 -1 O SER C 212 N ILE C 195 SHEET 3 AA4 3 ILE C 200 LYS C 201 -1 N ILE C 200 O ASN C 208 SHEET 1 AA5 8 VAL C 194 THR C 196 0 SHEET 2 AA5 8 PHE C 207 LYS C 214 -1 O SER C 212 N ILE C 195 SHEET 3 AA5 8 LYS C 160 PHE C 168 -1 N TYR C 161 O LEU C 213 SHEET 4 AA5 8 ALA C 144 LEU C 147 -1 N ARG C 146 O GLU C 164 SHEET 5 AA5 8 LEU E 239 PHE E 243 1 O ASN E 242 N LEU C 147 SHEET 6 AA5 8 VAL E 225 HIS E 232 -1 N VAL E 230 O LEU E 239 SHEET 7 AA5 8 ILE E 173 GLN E 180 -1 N THR E 176 O VAL E 229 SHEET 8 AA5 8 PRO E 187 GLU E 189 -1 O ILE E 188 N LYS E 179 SHEET 1 AA6 8 ILE C 188 GLU C 189 0 SHEET 2 AA6 8 ASN C 174 GLN C 180 -1 N LYS C 179 O ILE C 188 SHEET 3 AA6 8 VAL C 225 ARG C 231 -1 O VAL C 229 N THR C 176 SHEET 4 AA6 8 LEU C 239 PHE C 243 -1 O PHE C 243 N TYR C 226 SHEET 5 AA6 8 ALA E 144 LEU E 147 1 O LEU E 147 N ASN C 242 SHEET 6 AA6 8 ASP E 159 PHE E 168 -1 O GLU E 164 N ARG E 146 SHEET 7 AA6 8 PHE E 207 LEU E 215 -1 O LEU E 213 N TYR E 161 SHEET 8 AA6 8 VAL E 194 THR E 196 -1 N ILE E 195 O SER E 212 SHEET 1 AA7 8 ILE C 188 GLU C 189 0 SHEET 2 AA7 8 ASN C 174 GLN C 180 -1 N LYS C 179 O ILE C 188 SHEET 3 AA7 8 VAL C 225 ARG C 231 -1 O VAL C 229 N THR C 176 SHEET 4 AA7 8 LEU C 239 PHE C 243 -1 O PHE C 243 N TYR C 226 SHEET 5 AA7 8 ALA E 144 LEU E 147 1 O LEU E 147 N ASN C 242 SHEET 6 AA7 8 ASP E 159 PHE E 168 -1 O GLU E 164 N ARG E 146 SHEET 7 AA7 8 PHE E 207 LEU E 215 -1 O LEU E 213 N TYR E 161 SHEET 8 AA7 8 ILE E 200 LYS E 201 -1 N ILE E 200 O ASN E 208 SHEET 1 AA8 2 LYS D 27 GLU D 29 0 SHEET 2 AA8 2 ASN D 49 PHE D 51 -1 O PHE D 51 N LYS D 27 SHEET 1 AA9 6 THR D 35 PRO D 39 0 SHEET 2 AA9 6 LEU D 129 VAL D 140 1 O GLN D 136 N GLN D 36 SHEET 3 AA9 6 GLY D 118 VAL D 126 -1 N VAL D 124 O ALA D 131 SHEET 4 AA9 6 MET D 61 LYS D 68 -1 N GLY D 62 O VAL D 125 SHEET 5 AA9 6 VAL D 76 PHE D 82 -1 O VAL D 78 N TRP D 65 SHEET 6 AA9 6 HIS D 85 ALA D 88 -1 O HIS D 85 N PHE D 82 SHEET 1 AB1 2 VAL D 44 ILE D 46 0 SHEET 2 AB1 2 LEU D 107 LEU D 109 -1 O LEU D 107 N ILE D 46 SHEET 1 AB2 4 ALA D 144 LEU D 148 0 SHEET 2 AB2 4 TYR D 161 PHE D 168 -1 O MET D 162 N LEU D 148 SHEET 3 AB2 4 PHE D 207 LEU D 213 -1 O LEU D 213 N TYR D 161 SHEET 4 AB2 4 VAL D 194 THR D 196 -1 N ILE D 195 O SER D 212 SHEET 1 AB3 4 ALA D 144 LEU D 148 0 SHEET 2 AB3 4 TYR D 161 PHE D 168 -1 O MET D 162 N LEU D 148 SHEET 3 AB3 4 PHE D 207 LEU D 213 -1 O LEU D 213 N TYR D 161 SHEET 4 AB3 4 ILE D 200 LYS D 201 -1 N ILE D 200 O ASN D 208 SHEET 1 AB4 4 ILE D 188 GLU D 189 0 SHEET 2 AB4 4 ILE D 173 GLN D 180 -1 N LYS D 179 O ILE D 188 SHEET 3 AB4 4 VAL D 225 HIS D 232 -1 O VAL D 229 N THR D 176 SHEET 4 AB4 4 LEU D 239 PHE D 243 -1 O PHE D 243 N TYR D 226 SHEET 1 AB5 2 VAL A 21 SER A 22 0 SHEET 2 AB5 2 SER A 40 PHE A 41 -1 O SER A 40 N SER A 22 SHEET 1 AB6 4 GLU A 26 LEU A 30 0 SHEET 2 AB6 4 THR A 123 GLU A 128 1 O VAL A 126 N ILE A 27 SHEET 3 AB6 4 SER A 104 VAL A 112 -1 N SER A 104 O LEU A 125 SHEET 4 AB6 4 GLY A 51 ARG A 57 -1 N PHE A 56 O VAL A 107 SHEET 1 AB7 4 GLU A 26 LEU A 30 0 SHEET 2 AB7 4 THR A 123 GLU A 128 1 O VAL A 126 N ILE A 27 SHEET 3 AB7 4 SER A 104 VAL A 112 -1 N SER A 104 O LEU A 125 SHEET 4 AB7 4 GLY A 116 THR A 119 -1 O GLY A 118 N VAL A 110 SHEET 1 AB8 3 ALA A 35 LEU A 37 0 SHEET 2 AB8 3 LEU A 93 ILE A 95 -1 O LEU A 93 N LEU A 37 SHEET 3 AB8 3 LEU A 77 ALA A 78 -1 N ALA A 78 O HIS A 94 SHEET 1 AB9 4 GLU B 26 LEU B 30 0 SHEET 2 AB9 4 THR B 123 GLU B 128 1 O VAL B 126 N ILE B 27 SHEET 3 AB9 4 SER B 104 VAL B 112 -1 N SER B 104 O LEU B 125 SHEET 4 AB9 4 GLY B 51 ARG B 57 -1 N PHE B 56 O VAL B 107 SHEET 1 AC1 4 GLU B 26 LEU B 30 0 SHEET 2 AC1 4 THR B 123 GLU B 128 1 O VAL B 126 N ILE B 27 SHEET 3 AC1 4 SER B 104 VAL B 112 -1 N SER B 104 O LEU B 125 SHEET 4 AC1 4 GLY B 116 THR B 119 -1 O GLY B 116 N VAL B 112 SHEET 1 AC2 2 ALA B 35 LEU B 37 0 SHEET 2 AC2 2 LEU B 93 ILE B 95 -1 O LEU B 93 N LEU B 37 SHEET 1 AC3 2 LYS E 27 GLU E 29 0 SHEET 2 AC3 2 ASN E 49 PHE E 51 -1 O PHE E 51 N LYS E 27 SHEET 1 AC4 6 THR E 35 PRO E 39 0 SHEET 2 AC4 6 LEU E 129 VAL E 140 1 O GLN E 136 N GLN E 36 SHEET 3 AC4 6 GLY E 118 VAL E 126 -1 N VAL E 124 O ALA E 131 SHEET 4 AC4 6 MET E 61 LYS E 68 -1 N GLY E 62 O VAL E 125 SHEET 5 AC4 6 VAL E 76 PHE E 81 -1 O VAL E 78 N TRP E 65 SHEET 6 AC4 6 GLN E 86 ALA E 88 -1 O GLU E 87 N GLU E 80 SHEET 1 AC5 2 VAL E 44 ILE E 46 0 SHEET 2 AC5 2 LEU E 107 LEU E 109 -1 O LEU E 107 N ILE E 46 SSBOND 1 CYS C 48 CYS C 122 1555 1555 2.04 SSBOND 2 CYS C 163 CYS C 228 1555 1555 2.02 SSBOND 3 CYS D 48 CYS D 122 1555 1555 2.04 SSBOND 4 CYS D 163 CYS D 228 1555 1555 2.06 SSBOND 5 CYS A 39 CYS A 108 1555 1555 2.02 SSBOND 6 CYS B 39 CYS B 108 1555 1555 2.02 SSBOND 7 CYS E 48 CYS E 122 1555 1555 2.05 SSBOND 8 CYS E 163 CYS E 228 1555 1555 2.00 LINK ND2 ASN C 208 C1 NAG C 301 1555 1555 1.45 LINK ND2 ASN D 208 C1 NAG D 301 1555 1555 1.45 LINK ND2 ASN A 42 C1 NAG A 201 1555 1555 1.44 LINK ND2 ASN B 42 C1 NAG B 201 1555 1555 1.45 LINK ND2 ASN E 43 C1 NAG E 301 1555 1555 1.44 CISPEP 1 THR C 127 PRO C 128 0 6.45 CISPEP 2 TYR C 169 PRO C 170 0 2.54 CISPEP 3 THR D 127 PRO D 128 0 6.14 CISPEP 4 TYR D 169 PRO D 170 0 2.54 CISPEP 5 THR E 127 PRO E 128 0 8.65 CISPEP 6 TYR E 169 PRO E 170 0 1.46 CRYST1 166.044 86.462 111.299 90.00 97.58 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006022 0.000000 0.000801 0.00000 SCALE2 0.000000 0.011566 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009064 0.00000